Report: FDA expected to OK 3rd vaccine dose for the immunocompromised
The Food and Drug Administration is preparing to revise its emergency use authorizations for the Pfizer and Moderna COVID-19 vaccines, allowing immunocompromised adults to get a third dose, two people familiar with the matter told NBC News.
The announcement is expected to come on Thursday, the people said. Both the Pfizer and Moderna vaccines involve two shots, but there is evidence that people who are immunocompromised may only develop low levels of antibodies after being vaccinated, if any at all. A recent study at Johns Hopkins University of organ transplant recipients, who take medicine to suppress their immune systems so their new organs aren't rejected, showed that a third vaccine dose increased their antibody levels.
In July, an advisory panel to the Centers for Disease Control and Prevention said extra doses must be approved for immunocompromised adults, who make up about 2.7 percent of the U.S. population.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Putin says Russia isn't weakened by Syria setback
Speed Read Russia had been one of the key backers of Syria's ousted Assad regime
By Peter Weber, The Week US Published
-
Georgia DA Fani Willis removed from Trump case
Speed Read Willis had been prosecuting the election interference case against the president-elect
By Rafi Schwartz, The Week US Published
-
Democrats blame 'President Musk' for looming shutdown
Speed Read The House of Representatives rejected a spending package that would've funding the government into 2025
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published